Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
2.290
-0.010 (-0.43%)
At close: Jul 24, 2026, 4:00 PM EDT
2.281
-0.009 (-0.41%)
After-hours: Jul 24, 2026, 7:48 PM EDT

Lexicon Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
69.6449.831.081.20.140.3
Revenue Growth
123.12%60.24%2481.48%766.19%-53.36%-98.76%
Gross Profit
69.2949.5330.471.120.140.3
Operating Income
-24.23-48.91-197.12-171.75-100.76-87.09
Net Income
-26.09-50.34-200.4-177.12-101.94-87.76
Earnings Per Share
-0.07-0.14-0.63-0.80-0.62-0.60
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
170.6696.23237.96170.03138.3686.74
Total Debt
49.6854100.399.51541.19
Net Cash (Debt)
120.9742.23137.6670.5284.3585.55
Net Cash Growth
28.50%-69.33%95.21%-16.40%-1.40%-39.16%
Net Cash Per Share
0.320.120.430.320.510.59

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-38.8-67.85-178.78-161.9-88.85-87.02
Capital Expenditures
---1.03-0.47-1.33-1.22
Free Cash Flow
-38.8-67.85-179.81-162.37-90.18-88.24
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
99.49%99.45%98.02%92.94%100.00%100.00%
Operating Margin
-34.79%-98.21%-634.20%-14265.00%-72489.20%-29224.80%
Pretax Margin
-41.52%-101.08%-644.78%-14710.88%-73341.01%-29448.99%
Profit Margin
-37.46%-101.08%-644.78%-14710.90%-73341.00%-29449.00%
FCF Margin
-55.72%-136.24%-578.52%-13485.60%-64875.50%-29610.10%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-25.1725.1725.1725.1725.17
PS Ratio
14.618.398.59311.242593.281968.90